Pillar Pacific Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$463K Sell
6,700
-700
-9% -$47.4K 0.04% 220
2020
Q4
$481K Hold
7,400
0.04% 216
2020
Q3
$350K Hold
7,400
0.03% 229
2020
Q2
$348K Hold
7,400
0.04% 216
2020
Q1
$330K Buy
7,400
+1,400
+23% +$73.5K 0.04% 197
2019
Q4
$350K Hold
6,000
0.04% 220
2019
Q3
$360K Sell
6,000
-250
-4% -$14.9K 0.04% 205
2019
Q2
$349K Sell
6,250
-250
-4% -$12.9K 0.04% 218
2019
Q1
$362K Sell
6,500
-225
-3% -$11.5K 0.04% 200
2018
Q4
$303K Hold
6,725
0.04% 207
2018
Q3
$443K Hold
6,725
0.05% 190
2018
Q2
$433K Buy
6,725
+250
+4% +$15.5K 0.05% 195
2018
Q1
$358K Sell
6,475
-375
-5% -$19.7K 0.04% 204
2017
Q4
$328K Sell
6,850
-150
-2% -$7.34K 0.04% 227
2017
Q3
$354K Hold
7,000
0.05% 216
2017
Q2
$381K Hold
7,000
0.05% 207
2017
Q1
$295K Hold
7,000
0.04% 238
2016
Q4
$300K Hold
7,000
0.05% 234
2016
Q3
$289K Hold
7,000
0.05% 234
2016
Q2
$280K Hold
7,000
0.05% 228
2016
Q1
$236K Buy
+7,000
New +$218K 0.04% 261

Other funds holding IART

Pillar Pacific Capital Management's IART Position: Q1 2021 in Review

Pillar Pacific Capital Management reduced its Integra LifeSciences (IART) stake by 9.5% in Q1 2021, selling an estimated $47.4K and leaving 6,700 shares worth $463K. The position accounts for 0.04% of the portfolio, ranked #220.

Pillar Pacific Capital Management first reported a position in IART in Q1 2016 and has held it in 21 quarters since. The position peaked at $481K in Q4 2020. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

  • Pillar Pacific Capital Management held 6,700 shares of Integra LifeSciences worth $463K as of Q1 2021.
  • Pillar Pacific Capital Management sold 700 Integra LifeSciences shares in Q1 2021, an estimated $47.4K.
  • Integra LifeSciences made up 0.04% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #220 holding.
  • Pillar Pacific Capital Management first reported a position in Integra LifeSciences in Q1 2016 and has held it in 21 quarters since.
  • Pillar Pacific Capital Management's Integra LifeSciences position peaked at $481K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.